What is the appropriate oral fluconazole dosage for cutaneous ringworm in a 116‑lb (≈52 kg) patient and a 63‑lb (≈29 kg) patient?

Fluconazole is NOT the Appropriate Treatment for Cutaneous Ringworm (Dermatophytosis)

Fluconazole should not be used for ringworm (tinea corporis/cruris) because it demonstrates poor efficacy against dermatophyte infections, with cure rates as low as 8% at 4 weeks and only 42% at 8 weeks in the current epidemic of altered dermatophytosis. 1

Why Fluconazole Fails for Ringworm

The evidence provided addresses Candida infections (yeast), not dermatophyte infections (the fungi that cause ringworm). These are fundamentally different organisms:

• All the guideline recommendations 2 and FDA labeling 3 discuss fluconazole for candidiasis (Candida species infections affecting mucosa, bloodstream, and urinary tract)—not for dermatophytosis. 2

• The IDSA Skin and Soft Tissue guideline 4 mentions fluconazole only for Candida skin infections in neutropenic patients, explicitly stating that Candida species should be treated with echinocandins or lipid amphotericin B as first-line agents. 4

Evidence Against Fluconazole for Ringworm

• In a 2020 randomized trial of 200 patients with chronic tinea corporis/cruris, fluconazole 5 mg/kg/day achieved only 8% cure at 4 weeks and 42% cure at 8 weeks—significantly inferior to itraconazole (66% cure at 8 weeks). 1

• Itraconazole was statistically superior to fluconazole (adjusted P ≤ 0.048), with a number-needed-to-treat of only 2 compared to griseofulvin baseline. 1

• Older studies from the 1990s 5, 6, 7 showing fluconazole efficacy for tinea corporis/cruris used 150 mg weekly for 2–4 weeks in uncomplicated, treatment-naïve infections—a clinical scenario that no longer reflects the current epidemic of chronic, relapsing, and treatment-resistant dermatophytosis in many regions. 1

Correct Treatment Options for Ringworm

First-Line Oral Therapy

For a 116-lb (52 kg) patient:

• Itraconazole 200 mg daily for 2 weeks (or 100 mg daily for 2 weeks as an alternative lower dose). 5

For a 63-lb (29 kg) patient (pediatric):

• Itraconazole 5 mg/kg/day for 2 weeks = approximately 145 mg daily (round to nearest available formulation). 1

Alternative Oral Agents

• Terbinafine 250 mg daily for 1–2 weeks (adults) or 7.5 mg/kg/day (pediatric: ~220 mg for 29 kg patient). 1, 5
• Griseofulvin 10 mg/kg/day (pediatric standard), though this showed the lowest cure rate (14% at 8 weeks) in the 2020 trial. 1

Critical Pitfalls to Avoid

• Do not prescribe fluconazole for ringworm based on outdated literature or convenience—current resistance patterns have rendered it largely ineffective. 1

• Do not assume all "fungal infections" respond to the same antifungal—Candida (yeast) and dermatophytes (molds) have different susceptibility profiles. 4, 1

• Do not use short-duration fluconazole regimens (e.g., single-dose or 1-week courses) for chronic or extensive tinea—even historical data required 2–4 weeks of weekly dosing, and modern strains are more resistant. 1, 6, 7

• In regions with altered dermatophytosis (India, parts of Asia), expect treatment failure with standard regimens and consider extending therapy duration or using combination approaches. 1

When Fluconazole IS Appropriate (Not for Ringworm)

Fluconazole remains the drug of choice for:

• Candida vulvovaginitis, oropharyngeal candidiasis, esophageal candidiasis (100–400 mg daily). 2
• Candidemia and invasive candidiasis (loading dose 800 mg, then 400 mg daily). 2
• Candida urinary tract infections (200–400 mg daily for cystitis/pyelonephritis). 8